perospirone has been researched along with Benign Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Inoue, S; Maeda, I; Ogawa, A; Terada, S; Yamada, N; Yoshiuchi, K | 1 |
| Kono, B; Kurosawa, H; Takei, D; Yomiya, K | 1 |
| Abe, K; Akagi, T; Matoba, M; Mawatari, H; Saito, O; Syuuto, C; Tagami, K; Takeno, N | 1 |
3 other study(ies) available for perospirone and Benign Neoplasms
| Article | Year |
|---|---|
Safety and Effectiveness of Perospirone in Comparison to Risperidone for Treatment of Delirium in Patients with Advanced Cancer: A Multicenter Prospective Observational Study in Real-World Psycho-Oncology Settings.
Topics: Aged; Antipsychotic Agents; Delirium; Humans; Isoindoles; Neoplasms; Psycho-Oncology; Risperidone; Thiazoles | 2022 |
[A study on the antiemetic effect and extrapyramidal symptoms of prochlorperazine versus perospirone for the control of nausea and vomiting due to opioid introduction].
Topics: Antiemetics; Basal Ganglia Diseases; Female; Humans; Isoindoles; Male; Middle Aged; Nausea; Neoplasms; Opioid-Related Disorders; Palliative Care; Prochlorperazine; Retrospective Studies; Thiazoles; Vomiting | 2013 |
Perospirone Exhibits Antiemetic Efficacy against Opioid-Induced Nausea in Patients with Advanced Cancer.
Topics: Analgesics, Opioid; Antiemetics; Antipsychotic Agents; Female; Humans; Isoindoles; Japan; Male; Nausea; Neoplasms; Pain; Retrospective Studies; Thiazoles | 2015 |